Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products
Authors:
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 164 (1) , 38-45
Abstract
No abstract availableKeywords
Funding Information
- Novartis Pharma
This publication has 29 references indexed in Scilit:
- The calcipotriol dose–irritation relationship: 48 hour occlusive testing in healthy volunteers using Finn Chambers®British Journal of Dermatology, 1998
- Assessment of the potential irritancy of oleic acid on human skin: Evaluation in vitro and in vivoToxicology in Vitro, 1996
- Endogenous Interleukin-1α Is Associated with Skin Irritation Induced by TributyltinToxicology and Applied Pharmacology, 1996
- Enhanced expression of IL‐8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers., tolerogens and irritantsExperimental Dermatology, 1994
- The skin immune system: progress in cutaneous biologyImmunology Today, 1993
- Use ofIN VITROSkin Recombinants to Evaluate Cutaneous Toxicity: A Preliminary StudyJournal of Toxicology- Cutaneous and Ocular Toxicology, 1992
- Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis)British Journal of Dermatology, 1991
- Topical tretinoin for photoaged skinJournal of the American Academy of Dermatology, 1986
- Lactate dehydrogenase and cell injuryCell Biochemistry and Function, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976